Atossa Genetics Inc (NASDAQ:ATOS)

1.78
Delayed Data
As of 4:00pm ET
 +0.04 / +2.30%
Today’s Change
0.80
Today|||52-Week Range
2.65
+24.48%
Year-to-Date

Today’s Trading

Previous close1.74
Today’s open1.74
Day’s range1.66 - 2.07
Volume934,380
Average volume (3 months)1,243,884
Market cap$42.7M
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-70.73%
Earnings growth (this year)+28.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+31.28%
P/E ratioNM
Price/Sales56.79
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
EVOKEvoke Pharma Inc-0.01-0.14%
CYANCyanotech Corp+0.15+1.79%
--Axim Biotechnologies...+0.20+19.05%
IBIOIbio Inc-0.01-0.78%
Data as of 3:59pm ET, 03/27/2015

Financials

Last reporting dateMarch 26, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$632.6K
Annual profit (last year)-$10.8M
Net profit margin-1,704.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Steven C. Quay
Senior Vice President-
Operations
Scott Youmans
Corporate headquarters
Seattle, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account